Concerns with the new biological research criteria for synucleinopathy
Lancet Neurol
.
2024 Jul;23(7):659-660.
doi: 10.1016/S1474-4422(24)00213-8.
Authors
Bradley F Boeve
1
,
Albert A Davis
2
,
Yo-El Ju
2
,
Kejal Kantarci
3
,
Wolfgang Singer
3
,
Aleks Videnovic
4
;
NAPS co-investigators
Collaborators
NAPS co-investigators
:
Alon Avidan
,
Don Bliwise
,
Brad Boeve
,
Meghan Campbell
,
Susan Criswell
,
Albert Gus Davis
,
Kevin Duff
,
Kaylena Ehgoetz-Martens
,
Jon Elliott
,
Tanis Ferman
,
Julie Fields
,
Leah Forsberg
,
Jean-Francois Gagnon
,
Ziv Gan-Or
,
Mike Howell
,
Michele Hu
,
Xiaoping Hu
,
Daniel Huddleston
,
Yo-El Ju
,
Kejal Kantarci
,
Paul Kotzbauer
,
Jason Langley
,
Miranda Lim
,
Val Lowe
,
Jenny McLeland
,
Mitch Miglis
,
Emmanuel Mignot
,
Lee Neilson
,
Amelie Pelletier
,
Ron Postuma
,
Owen Ross
,
Carlos Schenck
,
Wolfgang Singer
,
Erik St Louis
,
Chengjie Xiong
Affiliations
1
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address:
[email protected]
.
2
Department of Neurology, Washington University, St. Louis, MO, USA.
3
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
4
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
PMID:
38876735
DOI:
10.1016/S1474-4422(24)00213-8
No abstract available
Publication types
Letter
MeSH terms
Biomedical Research / methods
Humans
Synucleinopathies*
Grants and funding
IK2 CX002539/CX/CSRD VA/United States
P30 AG066518/AG/NIA NIH HHS/United States
R34 AG056639/AG/NIA NIH HHS/United States
U19 AG071754/AG/NIA NIH HHS/United States